Latest News
29th Apr 2013 ImmunoReagents, the global manufacturer of high quality antibody products to the diagnostic and research industry, has entered into a non-exclusive in-licensing deal to use Innova Biosciences (Cambridge, UK) Lightning-Link® technology for commercial purposes.
Through the commercialisation deal, ImmunoReagents... |
19th Feb 2013 World healthcare models are continuously facing financial challenges when it comes to providing for an ageing population. The current models for provision are increasingly questioned with the upward trend in healthcare spending becoming a significant portion of the GDP. One solution to alleviate the... |
14th Jan 2013 Innova Biosciences (Cambridge, UK) the original manufacturer and provider of high quality bioconjugation services, used primarily in research, diagnostics and the biotech industry, announced today that it has recently achieved ISO 9001:2008 certification.
Innova Biosciences has had its work processes... |
3rd Dec 2012 Innova Biosciences (Cambridge, UK), inventor of the world’s easiest to use bioconjugation kits, is pleased to announce the appointment of Dr Andrew Lane as a new Executive Director onto its Board. In addition, Tim Bernard, a non-executive director with Innova for 4 years, will become the company’s... |
25th Sep 2012 Innova Biosciences (Cambridge, UK), inventor of the world’s easiest to use bioconjugation kits, is pleased to announce that the company has entered into a licensing agreement with StressMarq Biosciences (British Columbia, Canada).
The non-exclusive license will allow StressMarq to use Innova’s unique... |
4th Sep 2012 Innova Biosciences Limited (Cambridge, UK) is pleased to announce that Dr Andrew Lane has joined the company as International Licensing Manager.
|
